Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
2024

Enhancing VSVΔ51 oncolytic virotherapy with Octyl itaconate

publication

Author Information

Author(s): Kurmasheva Naziia, Said Aida, Wong Boaz, Kinderman Priscilla, Han Xiaoying, Rahimic Anna H. F., Kress Alena, Carter-Timofte Madalina E., Holm Emilia, van der Horst Demi, Kollmann Christoph F., Liu Zhenlong, Wang Chen, Hoang Huy-Dung, Kovalenko Elina, Chrysopoulou Maria, Twayana Krishna Sundar, Ottosen Rasmus N., Svenningsen Esben B., Begnini Fabio, Kiib Anders E., Kromm Florian E. H., Weiss Hauke J., Di Carlo Daniele, Muscolini Michela, Higgins Maureen, van der Heijden Mirte, Arulanandam Rozanne, Bardoul Angelina, Tong Tong, Ozsvar Attila, Hou Wen-Hsien, Schack Vivien R., Holm Christian K., Zheng Yunan, Ruzek Melanie, Kalucka Joanna, de la Vega Laureano, Elgaher Walid A. M., Korshoej Anders R., Lin Rongtuan, Hiscott John, Poulsen Thomas B., O’Neill Luke A., Roy Dominic G., Rinschen Markus M., van Montfoort Nadine, Diallo Jean-Simon, Farin Henner F., Alain Tommy, Olagnier David

Conclusion

The study corrects the author list and acknowledges funding for the research.

Takeaway

This article is about a correction to a previous study, adding an author and funding information.

Digital Object Identifier (DOI)

10.1038/s41467-024-55044-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication